Brought to you by:
SVS Foundation grant fuels barbershop-based PAD screening in Philadelphia
A single Philadelphia zip code once carried one of the highest rates of non-traumatic limb amputation in the country. Three years into a screening program built around an unlikely setting — the neighborhood barbershop — that number has fallen sharply…
Study supports routine vein mapping before CLTI revascularization
Many patients with chronic limb-threatening ischemia (CLTI) have suitable great saphenous vein (GSV) for bypass surgery, according to research published in the Journal of Vascular Surgery. The findings highlight the importance of routine vein mapping before revascularization. The study was…
Poverty plays growing role in major amputation risk
Major lower extremity amputations were once heavily concentrated in a narrow band of under-resourced, safety-net hospitals. A three-decade national study now shows that burden has spread well beyond those settings and that poverty is a more powerful predictor of limb…
Moving limb preservation forward with Shockwave Javelin Peripheral Intravascular Lithotripsy
This advertorial is sponsored by Shockwave Medical. Chronic limb-threatening ischemia (CLTI) represents the most advanced stage of peripheral artery disease (PAD) and carries a significant risk of major amputation if left untreated. Calcified tibial lesions remain among the most technically…
From reactive to proactive: CHAMPIONS builds nationwide effort around PAD prevention
“We’ve always approached peripheral artery disease in a very reactive way in that we wait for a patient to show up in our office or the emergency room with claudication, rest pain or gangrene and only then do we intervene,…
SEISMIQ IVL offers targeted approach to increasingly complex PAD
This video is sponsored by Boston Scientific. Nicolas Mouawad, MD, chief of vascular surgery at McLaren Health in Bay City, Michigan, discussed the growing challenge of treating peripheral artery disease (PAD) as an aging patient population presents with increasingly complex,…
Study links clopidogrel genetic variants to cardiovascular risk after PAD intervention
Genetic variants that reduce the effectiveness of clopidogrel may increase the risk of heart attack and stroke in patients undergoing peripheral artery disease (PAD) interventions, according to research presented at VAM 2026. The study found that around one in five…
‘Treat the water, not just the pipes’: Addressing prevention in vascular care
“The artery is ours and it should be all of it,” said Lily Johnston, MD. “Trying to reroute the blood flow without changing what runs through it is like changing the pipes in a house without addressing the toxic wastewater…
Elective PVI for claudication linked to worse limb outcomes and higher costs
Vascular surgeons have long debated whether and when to intervene on claudication. A new study suggests the field may be intervening too often, too early and with consequences that compound over time. The findings, recently published in the Journal of…
Rethinking antiplatelet and anticoagulant use in PAD after AQUATIC
During Thursday’s Hot Topics session, John Curci, MD, an associate professor at Vanderbilt Health, discussed the changing landscape of long-term antiplatelet and anticoagulant use in the management of peripheral artery disease (PAD) in light of results from the AQUATIC trial.…